The contribution of stem cell therapy to skeletal muscle remodeling in heart failure.

[1]  A. Cenedese,et al.  Amniotic Fluid Stem Cells Restore the Muscle Cell Niche in a HSA‐Cre, SmnF7/F7 Mouse Model , 2012, Stem cells.

[2]  G. Remuzzi,et al.  Human amniotic fluid stem cell preconditioning improves their regenerative potential. , 2012, Stem cells and development.

[3]  M. Pozzobon,et al.  Activation of Regulatory T Cells during Inflammatory Response Is Not an Exclusive Property of Stem Cells , 2012, PloS one.

[4]  R. Goldenberg,et al.  Adipose-derived stem-cell treatment of skeletal muscle injury. , 2012, The Journal of bone and joint surgery. American volume.

[5]  A. Angelini,et al.  Stem-cell therapy in an experimental model of pulmonary hypertension and right heart failure: role of paracrine and neurohormonal milieu in the remodeling process. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[6]  D. Mele,et al.  Exercise intolerance in chronic heart failure: mechanisms and therapies. Part I , 2010, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[7]  D. Mele,et al.  Exercise intolerance in chronic heart failure: mechanisms and therapies. Part II , 2010, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[8]  A. Angelini,et al.  Bone-marrow-derived CXCR4-positive tissue-committed stem cell recruitment in human right ventricular remodeling. , 2010, Human pathology.

[9]  M. Tarnopolsky,et al.  Satellite cell number and cell cycle kinetics in response to acute myotrauma in humans: immunohistochemistry versus flow cytometry , 2010, The Journal of physiology.

[10]  A. Angelini,et al.  Skeletal muscle proteins oxidation in chronic right heart failure in rats: can different beta-blockers prevent it to the same degree? , 2010, International journal of cardiology.

[11]  Noel R. Rose,et al.  Proinflammatory cytokines in heart failure: double-edged swords , 2010, Heart Failure Reviews.

[12]  Joshua M Hare,et al.  Inflammatory cytokines in heart failure: roles in aetiology and utility as biomarkers. , 2010, European heart journal.

[13]  P. Coppi,et al.  Increased adipogenic conversion of muscle satellite cells in obese Zucker rats , 2010, International Journal of Obesity.

[14]  R. Rizzuto,et al.  The origin of intermuscular adipose tissue and its pathophysiological implications. , 2009, American journal of physiology. Endocrinology and metabolism.

[15]  L. Hsu,et al.  Human bone marrow-derived adult stem cells for post-myocardial infarction cardiac repair: current status and future directions. , 2009, Singapore medical journal.

[16]  A. Hatzopoulos,et al.  Cardiac repair and regeneration: the Rubik’s cube of cell therapy for heart disease , 2009, Disease Models & Mechanisms.

[17]  E. Cartocci,et al.  The membrane expression of Neisseria meningitidis adhesin A (NadA) increases the proimmune effects of MenB OMVs on human macrophages, compared with NadA– OMVs, without further stimulating their proinflammatory activity on circulating monocytes , 2009, Journal of leukocyte biology.

[18]  G. Lin,et al.  Defining stem and progenitor cells within adipose tissue. , 2008, Stem cells and development.

[19]  M. Gnecchi,et al.  Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy , 2008, Circulation research.

[20]  P. Zammit.  All muscle satellite cells are equal, but are some more equal than others? , 2008, Journal of Cell Science.

[21]  A. Angelini,et al.  Skeletal muscle wastage in Crohn's disease: a pathway shared with heart failure? , 2008, International journal of cardiology.

[22]  J. Lasky,et al.  Bone marrow progenitor cells contribute to repair and remodeling of the lung and heart in a rat model of progressive pulmonary hypertension , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  A. Angelini,et al.  Continuous engraftment and differentiation of male recipient Y-chromosome-positive cardiomyocytes in donor female human heart transplants. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[24]  Anthony Atala,et al.  Isolation of amniotic stem cell lines with potential for therapy , 2007, Nature Biotechnology.

[25]  A. Angelini,et al.  Human amniotic fluid-derived stem cells are rejected after transplantation in the myocardium of normal, ischemic, immuno-suppressed or immuno-deficient rat. , 2007, Journal of molecular and cellular cardiology.

[26]  G. Thiene,et al.  Hybrid cardiomyocytes derived by cell fusion in heterotopic cardiac xenografts , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  F. Crea,et al.  Myogenic potential of adipose-tissue-derived cells , 2006, Journal of Cell Science.

[28]  L. D. Libera,et al.  Skeletal muscle apoptosis in experimental heart failure: the only link between inflammation and skeletal muscle wastage? , 2006, Current opinion in clinical nutrition and metabolic care.

[29]  P. Singal,et al.  Significance of changes in TNF-alpha and IL-10 levels in the progression of heart failure subsequent to myocardial infarction. , 2006, American journal of physiology. Heart and circulatory physiology.

[30]  J. Ingwall,et al.  Evidence supporting paracrine hypothesis for Akt‐modified mesenchymal stem cell‐mediated cardiac protection and functional improvement , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  G. Thiene,et al.  Host-derived circulating cells do not significantly contribute to cardiac regeneration in heterotopic rat heart transplants. , 2005, Cardiovascular research.

[32]  A. Angelini,et al.  Amniotic mesenchymal cells autotransplanted in a porcine model of cardiac ischemia do not differentiate to cardiogenic phenotypes. , 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[33]  A. Angelini,et al.  Skeletal muscle fibres synthesis in heart failure: role of PGC-1alpha, calcineurin and GH. , 2005, International journal of cardiology.

[34]  T. Ueland,et al.  Inflammatory and anti‐inflammatory cytokines in chronic heart failure: Potential therapeutic implications , 2005, Annals of medicine.

[35]  Marco Sandri,et al.  Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy , 2004, Cell.

[36]  L. Casteilla,et al.  Transplantation of Adipose Tissue-Derived Stromal Cells Increases Mass and Functional Capacity of Damaged Skeletal Muscle , 2004, Cell transplantation.

[37]  D. Mann,et al.  Exercise training and skeletal muscle inflammation in chronic heart failure: feeling better about fatigue. , 2003, Journal of the American College of Cardiology.

[38]  G. Schuler,et al.  Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure. , 2003, Journal of the American College of Cardiology.

[39]  A. Angelini,et al.  L-Carnitine: a potential treatment for blocking apoptosis and preventing skeletal muscle myopathy in heart failure. , 2002, American journal of physiology. Cell physiology.

[40]  A. Angelini,et al.  Effect of thalidomide on the skeletal muscle in experimental heart failure , 2002, European journal of heart failure.

[41]  A. Angelini,et al.  Apoptosis in the skeletal muscle of rats with heart failure is associated with increased serum levels of TNF-alpha and sphingosine. , 2001, Journal of molecular and cellular cardiology.

[42]  A. Angelini,et al.  Beneficial Effects on Skeletal Muscle of the Angiotensin II Type 1 Receptor Blocker Irbesartan in Experimental Heart Failure , 2001, Circulation.

[43]  R. Ferrari,et al.  Apoptosis in the skeletal muscle of patients with heart failure: investigation of clinical and biochemical changes , 2000, Heart.

[44]  M. Sandri,et al.  Apoptosis and atrophy in rat slow skeletal muscles in chronic heart failure. , 1999, American journal of physiology. Cell physiology.

[45]  S. Anker,et al.  Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation. , 1999, Chest.

[46]  M. Sandri,et al.  Apoptosis of skeletal muscle myofibers and interstitial cells in experimental heart failure. , 1998, Journal of molecular and cellular cardiology.

[47]  M. Volterrani,et al.  Improved exercise tolerance after losartan and enalapril in heart failure: correlation with changes in skeletal muscle myosin heavy chain composition. , 1998, Circulation.

[48]  M. Piepoli,et al.  Contribution of muscle afferents to the hemodynamic, autonomic, and ventilatory responses to exercise in patients with chronic heart failure: effects of physical training. , 1996, Circulation.

[49]  P. Poole‐Wilson,et al.  Symptoms and quality of life in heart failure: the muscle hypothesis. , 1994, British heart journal.

[50]  Wan Ariffin Bin Abdullah.  Singapore Med J , 1993 .

[51]  S. Corvera,et al.  The vascular endothelium of the adipose tissue gives rise to both white and brown fat cells , 2012 .

[52]  A. Angelini,et al.  Beneficial effects of GH/IGF-1 on skeletal muscle atrophy and function in experimental heart failure. , 2004, American journal of physiology. Cell physiology.